7Baggers
 Acrivon Therapeutics stock rating reiterated by Citizens with $13 target  Investing.com Nigeria Mon, 17 Nov 2025 12:09:35 GMT
 td cowen maintains acrivon therapeutics(acrv.us) with buy rating  富途牛牛 Fri, 14 Nov 2025 05:31:00 GMT
 Acrivon Therapeutics Reports Q3 2025 Financial Results  TipRanks Fri, 14 Nov 2025 05:05:32 GMT
 Acrivon Therapeutics Narrows Losses And Draws Analyst Support  Finimize Fri, 14 Nov 2025 02:47:39 GMT
 Acrivon Therapeutics Shrinks Losses And Draws Analyst Optimism  Finimize Fri, 14 Nov 2025 01:11:01 GMT
 Acrivon Therapeutics reports Q3 EPS (47c), consensus (58c)  TipRanks Thu, 13 Nov 2025 22:22:33 GMT
 Acrivon Therapeutics reports preclinical data on ACR-2316  BioWorld MedTech Thu, 06 Nov 2025 13:00:00 GMT
 acrivon therapeutics (acrv) to release earnings on wednesday  MarketBeat Wed, 05 Nov 2025 12:08:59 GMT
 3 Promising Penny Stocks With Market Caps Over $20M  simplywall.st Tue, 04 Nov 2025 17:07:30 GMT
 acrivon to present data on ai-driven cancer drug development at conference  Investing.com Australia Thu, 23 Oct 2025 11:51:43 GMT

Acrivon Therapeutics, Inc.
(NASDAQ:ACRV) 

ACRV stock logo

Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to specific medicine by utilizing its proteomics-based patient responder identification platform, Acrivon ...

Founded: 2018
Full Time Employees: 35
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends